Abstract
In this paper, the chromatographic characterization of fosinopril sodium and fosinoprilat is presented. The first stept was pK a determination for the active substance and its degradation product using RP-LC. It was followed by optimization employing the combination of experimental design and artificial neural networks. For the definition of input and output variables, the central composite design for three factors was built. Back propagation algorithm was applied to model the system, and then the optimization of the experimental conditions was carried out in the neural network with 3-8-2 structure, which confirmed to be able to provide the maximum performance. From the method optimization, the most appropriate experimental conditions for fosinopril sodium and fosinoprilat analysis were extracted. The optimized method was validated and applied in the quality control of tablets and for forced degradation studies.
Similar content being viewed by others
References
Hameda AB, Elosta S, Havel J (2005) J Chromatogr A 1084:7–12
Novotna K, Havliš J, Havel J (2005) J Chromatogr A 1096:50–57
Marengo E, Gianotti V, Angioi S, Gennaro MC (2004) J Chromatogr A 1029:57–65
Tran ATK, Hyne RV, Pablo F, Day WR, Doble P (2006) Talanta 71:1268–1275
Havel J, Madden JE, Haddad PR (1999) Chromatographia 49:481–488
Wang H, Liu W (2004) J Sep Sci 27:1189–1194
Siouffi AM, Phan-Tan-Luu R (2000) J Chromatogr A 892:75–106
Arulsudar N, Subramanian N, Murthy RSR (2005) J Pharm Pharm Sci 8:243–258
Glass BD, Agatonovic-Kustrin S, Wisch MH (2005) Curr Drug Discov Technol 2(3):195–201
Takayama K, Fujikawa M, Nagai T (1999) Pharm Res 16(1):1–6
Gašperlin M, Tušar L, Tušar M, Kristl J, Šmid-Korbar J (1998) Int J Pharm 168:243–245
Tham SZ, Agatonovic-Kustrin S (2002) J Pharm Biomed Anal 28:581–590
Ruggieri F, D′Archivio AA, Carlucci G, Mazzeo P (2005) J Chromatogr A 1076:163–169
Magri AL, Balestrieri F, Magri AD, Marini D (1995) Talanta 42:1719–1723
Saglik S, Sagirli O, Atmaca S, Ersoy L (2000) Anal Chim Acta 427(2):253–257
Erk N (2002) J Pharm Biomed Anal 27(6):901–912
Ozkan SA, Akay C, Cevheroglu S, Saenurk Z (2001) J Liq Chromatogr 24(7):983–991
Lozano R, Warren FV, Perlman S, Joseph JM (1995) J Pharm Biomed Anal 13:139–148
Hillaert S, Vander Heyden Y, Van den Bossche W (2002) J Chromatogr A 978:231–242
Hillaert S, Van den Bossche W (2000) J Chromatogr A 895:33–42
Hillaert S, De Grauwe K, Van den Bossche W (2001) J Chromatogr A 924:325–331
Hillaert S, Van den Bossche W (2001) J Pharm Biomed Anal 25:775–793
Jemal M, Ivashkiv E, Ribick M, Cohen AI (1985) J Chromatogr 345:299–307
Jemal M, Mulvanab DE (2000) J Chromatogr B 739:255–271
Jemal M, Huang M, Mao Y, Whiga D, Schuster A (2000) Rapid Commun Mass Spectrom 14(12):1023–1028
Jančić B, Ivanović D, Medenica M, Malenović A, Dimković N (2005) J Chromatogr A 1008:187–192
Lewen N, Schenkenberger M, Larkin T, Conder S, Brittain HG (1995) J Pharm Biomed Anal 13:879–883
Jančić B, Ivanović D, Medenica M, Malenović A (2003) Acta Chim Slov 50:327–333
Ivanović D, Medenica M, Jančić B, Malenović A, Marković S (2004) Chromatographia 60:S87–S92
Jančić B, Medenica M, Ivanović D, Malenović A, Marković S (2005) Anal Bioanal Chem 383:687–694
Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011–1040
Chandran S, Singh SP (2007) Pharmazie 62:4–14
Acknowledgments
The authors thank the Ministry of Science for supporting these investigations in Project 142077G.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Biljana, J., Mirjana, M., Darko, I. et al. Chromatographic Behavior of Fosinopril Sodium and Fosinoprilat Using Neural Networks. Chroma 67 (Suppl 1), 123–127 (2008). https://doi.org/10.1365/s10337-008-0575-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0575-9